Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Rentokil Initial plc Sponsored ADR (RTO) Stock Forecast & Price Prediction United Kingdom | NYSE | Industrials | Specialty Business Services
$23.38
+0.01 (0.04%)10 Quality Stocks Worth Considering Now
Researching Rentokil (RTO) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on RTO and similar high-potential opportunities.
Based on our analysis of 4 Wall Street analysts, RTO has a bullish consensus with a median price target of $30.79 (ranging from $28.00 to $32.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $23.38, the median forecast implies a 31.7% upside. This outlook is supported by 3 Buy, 1 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for RTO.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Sep 19, 2024 | Redburn Atlantic | Oliver Davies | Neutral | Downgrade | $0.00 |
Jul 1, 2024 | UBS | Neutral | Upgrade | $0.00 | |
Mar 18, 2024 | Exane BNP Paribas | Outperform | Upgrade | $0.00 | |
Jan 24, 2024 | B of A Securities | Simona Sarli | Neutral | Downgrade | $29.00 |
May 22, 2023 | Oppenheimer | Ian Zaffino | Outperform | Maintains | $47.00 |
The following stocks are similar to Rentokil based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Rentokil Initial plc Sponsored ADR has a market capitalization of $11.75B with a P/E ratio of 29.2x. The company generates $7.24B in trailing twelve-month revenue with a 5.6% profit margin.
Revenue growth is +1.0% quarter-over-quarter, while maintaining an operating margin of +11.4% and return on equity of +7.4%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Provides pest control and hygiene services globally.
The company operates on a service-based model, generating revenue through pest control, hygiene, and plant services. By offering essential services across various sectors, it caters to a diverse clientele, enhancing safety and cleanliness in their environments.
Rentokil Initial operates in over 80 countries and is recognized for its commitment to sustainability and innovation. The availability of its Sponsored ADR allows US investors to access international growth opportunities and diversify their investment portfolios.
Industrials
Specialty Business Services
68,485
Mr. Andrew M. Ransom
United Kingdom
1996
Pomerantz LLP is investigating claims for investors of Rentokil Initial plc (NYSE:RTO). Interested parties should contact Danielle Peyton for more information.
The investigation by Pomerantz LLP into Rentokil Initial plc may signal potential legal issues or financial irregularities, impacting investor confidence and stock performance.
Rentokil Initial PLC shares declined 1.6% following strong Q1 results from US competitor Rollins Inc, which reported 7.4% organic revenue growth, highlighting Rentokil's North American struggles.
Rentokil's share decline reflects concerns over its North American performance compared to Rollins' strong growth, signaling potential challenges in market competitiveness and investor confidence.
Rentokil Initial PLC reported a 0.7% organic revenue growth in North America for Q1, citing weak lead generation and lower contract sales in residential and commercial sectors.
Rentokil's weak Q1 growth signals potential challenges in its North American market, possibly affecting future earnings and stock performance, raising concerns for investor sentiment.
Rentokil Initial plc (NYSE:RTO) will hold a Q1 2025 Trading Update Call on April 17, 2025, at 4:00 AM ET, featuring CEO Andy Ransom and CFO Paul Edgecliffe-Johnson.
The Q1 trading update from Rentokil Initial provides insights into the company's financial health and performance trends, impacting stock valuations and investor sentiment.
Terminix released its annual list of the Top 50 Most Mosquito-Infested Cities in the U.S., based on 2024 data from over 300 branches.
Increased mosquito infestations can boost demand for pest control services, potentially enhancing Terminix's revenue and profitability, impacting its stock performance positively.
The Company has filed its Annual Report for 2024, Notice of the 2025 AGM, and Proxy Form with the FCA. Documents are available for inspection and on the Companyโs website.
The filing of the Annual Report and AGM notice provides transparency on company performance and governance, crucial for assessing future profitability and stability, impacting investor confidence and decisions.
Based on our analysis of 4 Wall Street analysts, Rentokil Initial plc Sponsored ADR (RTO) has a median price target of $30.79. The highest price target is $32.00 and the lowest is $28.00.
According to current analyst ratings, RTO has 3 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $23.38. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict RTO stock could reach $30.79 in the next 12 months. This represents a 31.7% increase from the current price of $23.38. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company operates on a service-based model, generating revenue through pest control, hygiene, and plant services. By offering essential services across various sectors, it caters to a diverse clientele, enhancing safety and cleanliness in their environments.
The highest price target for RTO is $32.00 from at , which represents a 36.9% increase from the current price of $23.38.
The lowest price target for RTO is $28.00 from at , which represents a 19.8% increase from the current price of $23.38.
The overall analyst consensus for RTO is bullish. Out of 4 Wall Street analysts, 3 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $30.79.
Stock price projections, including those for Rentokil Initial plc Sponsored ADR, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.